Ketamine Effects as Preemptive Analgesia
- Registration Number
- NCT06040060
- Lead Sponsor
- Universitas Padjadjaran
- Brief Summary
The goal of this randomized controlled trial is to compare the effect of preemptive ketamine administration to placebo administration in patients underwent hysterectomy surgery. The main questions it aims to answer are:
1. To determine the effect of ketamine at a dose of 0.5 mg/kgBW as preemptive analgesia on the duration of analgesia after hysterectomy surgery
2. To determine the effect of ketamine at a dose of 0.5 mg/kgBW as preemptive analgesia on the need for fentanyl after hysterectomy surgery
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 40
- Patients aged 18-50 years.
- ASA I and II physical status (American Society of Anesthesiologists).
- The patient is not willing to be included as a research subject
- The patient takes anti-pain medication before surgery
- History of allergies to the drugs to be used
- History of chronic pain
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Placebo Placebo Placebo administration of 10 mL NaCl 0,9% intravenously, given 10 minutes prior to incision Preemptive Ketamine Ketamine Preemptive administration of Ketamine 0.5 mg/kgBB intravenously, given 10 minutes prior to incision
- Primary Outcome Measures
Name Time Method Duration of postoperative analgesia 24 hours post operative Time interval from completion of hysterectomy until additional analgesic is needed, namely fentanyl 25 µg via PCA
Total need for post-operative analgesic rescue 24 hours post operative The total amount of rescue analgetic required by research subjects, during the 24 hours after surgery, was given via PCA
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Universitas Padjadjaran
🇮🇩Bandung, West Java, Indonesia